S&P 500 Hits New Highs; BofA Flags Slowing CTA Flow

The S&P 500 recorded fresh intraday and closing highs on May 9, 2026 while Bank of America Global Research published a note the previous day warning that systematic Commodity Trading Advisor (CTA) buying has lost momentum. The juxtaposition — index strength alongside fading mechanical demand from CTAs — has caught the attention of institutional desks because CTAs have been reliable marginal buyers during 2026’s risk-on episodes. BofA's note dated May 8, 2026 stated that weekly directional buying from CTAs has decelerated materially, to roughly $1 billion a week from approximately $3.5 billion in March, a shift that could reduce a key source of liquidity into futures and ETFs (BofA Global Research, May 8, 2026). For portfolio managers, the question is whether discretionary and fundamental flows can absorb equities’ advance if a technical bid from CTAs dissipates.

Context

The recent S&P 500 highs follow a multi-month rally driven by dovish messaging from major central banks, a resilient macro backdrop, and concentrated leadership among mega-cap growth names. On May 9, 2026 the index set new highs after a string of earnings beats from top-weighted constituents, with information technology and consumer discretionary sectors contributing the majority of upside. Year-to-date performance for the S&P 500 stands materially positive versus the same period in 2025: through the first week of May 2026 the index had gained approximately 6.5% YTD compared with a 3.1% YTD gain over the same window in 2025, highlighting a stronger cyclical momentum this year (Source: Exchange-level returns, May 2026). Market breadth, however, has been narrower than historical rallies: the top 10 names now account for a larger share of market cap and returns than the bottom 490 companies, echoing mid-cycle patterns where concentrated leadership masks dispersion.

The role of CTAs is central to interpreting price action at these highs. CTAs, which use trend-following algorithms across futures markets, were net buyers of equity futures for much of Q1 2026 and contributed to convex buying dynamics in risk assets. According to BofA (May 8, 2026), CTA directional signals — a composite metric of momentum across liquid futures — weakened materially in late April, translating into a decline in notional weekly buying. This matters because systematic buyers can amplify rallies during positive trend identification and conversely accelerate selling when trends reverse. In prior episodes, notably 2019 and the 2020-21 reflation, CTA flows accounted for mid-single-digit to low-double-digit percentages of daily futures volume during meaningful trending periods (historical CTA contribution: 5–15% of daily futures notional in major rallies, CFTC historical analyses).

Data Deep Dive

Bank of America Global Research's note (May 8, 2026) quantifies the slowdown: CTA directional buying dropped to an estimated $1 billion per week in early May from roughly $3.5 billion per week in March 2026. The CFTC speculative positioning snapshots and broker dealer flow reports corroborate a visible decline in CTA net long futures exposure across equity and interest rate sectors between March 1 and May 1, 2026. For instance, CTA exposure to E-mini S&P futures (ES) reduced by an estimated 18% over that period, while gross notional across equity futures decreased by about 12% (Sources: BofA Global Research May 8, 2026; broker flow summaries, May 2026).

Contrast the CTA trajectory with retail and institutional discretionary flows. Net mutual fund and ETF flows into U.S. equity products remained positive in April 2026, with ETF inflows of roughly $14 billion for the month versus mutual fund inflows of $4.2 billion (data: asset manager monthly flows, April 2026). That divergence — steady passive and active fundamental flows but weaker CTA participation — implies that passive accumulation and concentrated earnings beats may sustain the index level without the mechanical reinforcement of systematic trend-followers. Yet when trend-following contribution wanes, volatility regimes tend to shift: realized volatility of the S&P 500 over the 30-day window ticked down to the low teens in May 2026 vs. mid-teens in March (Source: Exchange-derived realized vol, May 2026), which compresses the immediate risk premium but increases vulnerability to exogenous shocks.

Sector Implications

If CTA buying continues to diminish, the most immediate market effect will be felt in highly liquid, large-cap names that are CTA targets via futures and liquid ETFs. Mega-cap technology names that constitute a heavy weight in the index — which have been the principal drivers of the recent new highs — are most susceptible to volatility spikes if systematic flows reverse. Conversely, small-cap and less liquid sectors, which historically benefit less from CTA flows, are likely to remain driven by fundamentals and discretionary flows. In practical terms, delta-sensitive products such as index futures, big-cap ETFs (SPY), and volatility products (VIX futures/options) will exhibit the largest intraday repricing if CTAs reduce presence further.

Banks and brokers providing prime brokerage and execution services may see margin and flow implications: lower CTA buying could reduce hedging demand across the listed futures complex, compressing commissions and reducing demand for block liquidity providers. Fixed-income markets could also experience knock-on effects; CTAs have increasingly traded duration as a portfolio hedge, and a pullback in their systematic activity could translate into lower cross-asset correlations in the short term. For institutional allocators, the practical consequence is an increase in idiosyncratic over systemic risk — returns will hinge more on earnings, economic data, and central bank communications than on trend-following bandwidth.

Risk Assessment

The principal risk is a regime shift from a trend-dominated to a dispersion-dominated market. Historically, when CTAs step back, markets can either reprice gently underpinned by fundamentals or suffer sudden retracements if discretionary selling coincides with a negative macro surprise. Given the current concentration of gains among a handful of names, a rotation or adverse shock could produce outsized headline damage to the index even if broader economic data remain constructive. Stress testing portfolios against a 10-15% drawdown in the top 10 mega-caps would be informative given their outsized contribution to headline returns in 2026.

Another risk vector is liquidity. CTA activity tends to provide consistent, predictable liquidity in futures and ETFs. A sustained reduction to low-single-digit weekly notional (as BofA estimates near $1bn/week in early May) reduces the pool of mechanical counterparties available to absorb large orders, especially during market stress. That elevates potential slippage and execution cost volatility for large institutional trades. Operationally, trading desks should reassess expected market impact models and liquidity premia, particularly for calendar-sensitive execution windows around macro prints or central bank decision dates.

Fazen Markets Perspective

While BofA's signal should not be dismissed, our view at Fazen Markets is that a decline in CTA directional buying does not automatically presage an equities reversal. Systematic trend-followers are only one component of the liquidity mosaic. Passive accumulation via ETFs and index funds has materially increased the baseline bid in U.S. equities; ETF inflows of $14 billion in April 2026 (asset manager data) are non-trivial and can offset a sizable portion of CTA softening. Moreover, discretionary market makers and quant liquidity providers have grown more sophisticated in hedging and cross-asset strategies, reducing sole reliance on CTAs for liquidity absorption.

A contrarian takeaway is that fading CTA momentum could actually create opportunities for mean-reversion strategies and selective alpha capture. With trend-driven premium reduced, dispersion strategies and active stock picking may outperform passive cap-weighted exposure on a relative basis. We also note that structural changes in market microstructure — such as concentrated index caps and high ETF share — mean that an attenuated CTA presence is less likely to trigger a systemic cascade than similar CTA drawdowns a decade ago. Institutional investors should nonetheless recalibrate execution assumptions and increase scenario analysis frequency: run both a slow-bleed 'CTA taper' scenario and a sharp 'CTA unwind' case to stress portfolio resilience.

Outlook

Near term, the S&P 500’s path will reflect a balance between earnings momentum from mega-cap leaders and the degree to which other flow engines — ETFs, pension rebalancing, and discretionary institutional buying — can compensate for CTA slack. If ETF inflows remain above the historical monthly average (for example, >$10 billion/month for U.S. equity ETFs), they are likely to underpin valuations in the absence of systematic trend buying. However, a negative surprise in macro data (inflation beats or an unexpected escalation in geopolitical risk) could amplify downside given thinner CTA support.

Over a three- to six-month horizon, rotational breadth improvement would be a constructive signal that the market is transitioning from a concentration-driven advance to a broader-based recovery; absent that, valuations will be increasingly tied to earnings trajectory in the top-weighted names. Portfolio managers should revisit liquidity assumptions for index futures and ETFs, perform concentrated-name stress tests, and consider increasing monitoring of CTA and quant-derived flow indicators, which historically precede volatility regime changes.

Bottom Line

The S&P 500’s new highs coexist with a measurable slowdown in CTA directional buying — a dynamic that calls for updated liquidity assumptions and targeted stress testing by institutional investors. Monitor ETF inflows, earnings concentration, and CTA signals closely for indications of regime change.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.